Annual ROE
-69.16%
-28.16%-68.68%
December 31, 2024
Summary
- As of March 10, 2025, PLRX annual return on equity is -69.16%, with the most recent change of -28.16% (-68.68%) on December 31, 2024.
- During the last 3 years, PLRX annual ROE has fallen by -28.81% (-71.40%).
- PLRX annual ROE is now -102.01% below its all-time high of 3432.65%, reached on December 31, 2018.
Performance
PLRX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-56.84%
-7.93%-16.21%
December 31, 2024
Summary
- As of March 10, 2025, PLRX quarterly return on equity is -56.84%, with the most recent change of -7.93% (-16.21%) on December 31, 2024.
- Over the past year, PLRX quarterly ROE has stayed the same.
- PLRX quarterly ROE is now -262.91% below its all-time high of 34.89%, reached on March 31, 2020.
Performance
PLRX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
PLRX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -68.7% | 0.0% |
| 3 y3 years | -71.4% | 0.0% |
| 5 y5 years | -147.7% | 0.0% |
PLRX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -71.4% | at low | -82.5% | at low |
| 5 y | 5-year | -147.7% | at low | -262.9% | at low |
| alltime | all time | -102.0% | at low | -262.9% | +51.5% |
Pliant Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | -69.16%(+68.7%) | -56.84%(+16.2%) |
| Sep 2024 | - | -48.91%(+19.1%) |
| Jun 2024 | - | -41.05%(+17.0%) |
| Mar 2024 | - | -35.08%(+12.6%) |
| Dec 2023 | -41.00%(-14.8%) | -31.15%(-4.2%) |
| Sep 2023 | - | -32.50%(-14.8%) |
| Jun 2023 | - | -38.14%(-11.9%) |
| Mar 2023 | - | -43.28%(-17.8%) |
| Dec 2022 | -48.13%(+19.3%) | -52.66%(+0.7%) |
| Sep 2022 | - | -52.31%(-5.6%) |
| Jun 2022 | - | -55.44%(+19.1%) |
| Mar 2022 | - | -46.53%(+15.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | -40.35%(+37.3%) | -40.17%(+14.9%) |
| Sep 2021 | - | -34.97%(+21.1%) |
| Jun 2021 | - | -28.87%(+2.3%) |
| Mar 2021 | - | -28.21%(+45.6%) |
| Dec 2020 | -29.39%(-120.3%) | -19.37%(-294.5%) |
| Sep 2020 | - | 9.96%(-29.3%) |
| Jun 2020 | - | 14.08%(-59.6%) |
| Mar 2020 | - | 34.89%(-1108.4%) |
| Dec 2019 | 145.06%(-95.8%) | -3.46%(-97.0%) |
| Sep 2019 | - | -117.17%(+44.9%) |
| Jun 2019 | - | -80.88%(+108.7%) |
| Mar 2019 | - | -38.75% |
| Dec 2018 | 3432.65% | - |
FAQ
- What is Pliant Therapeutics annual return on equity?
- What is the all time high annual ROE for Pliant Therapeutics?
- What is Pliant Therapeutics annual ROE year-on-year change?
- What is Pliant Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Pliant Therapeutics?
- What is Pliant Therapeutics quarterly ROE year-on-year change?
What is Pliant Therapeutics annual return on equity?
The current annual ROE of PLRX is -69.16%
What is the all time high annual ROE for Pliant Therapeutics?
Pliant Therapeutics all-time high annual return on equity is 3432.65%
What is Pliant Therapeutics annual ROE year-on-year change?
Over the past year, PLRX annual return on equity has changed by -28.16% (-68.68%)
What is Pliant Therapeutics quarterly return on equity?
The current quarterly ROE of PLRX is -56.84%
What is the all time high quarterly ROE for Pliant Therapeutics?
Pliant Therapeutics all-time high quarterly return on equity is 34.89%
What is Pliant Therapeutics quarterly ROE year-on-year change?
Over the past year, PLRX quarterly return on equity has changed by 0.00% (0.00%)